Skip to Main Content

Paper Details

The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
Clinical Chemistry and Laboratory Medicine
27
2021
COVID-19, MR-pro-adrenomedullin, MR-proADM, Midregional pro-adrenomedullin, acute respiratory syndrome, coronavirus 2 disease, patients, sepsis
Author NameAffiliation
Angelika Hammerer-LercherInstitute of Laboratory Medicine
  • 1 - 1

Datasets

Release 1.2